AI Article Synopsis
- The study aimed to evaluate the effectiveness of piracetam and acyclovir in treating sudden hearing loss among 81 patients.
- All participants, averaging 40.4 years old, were categorized into four treatment groups with varying combinations of these medications.
- Results showed no significant differences in hearing improvements across the treatment groups, indicating that acyclovir and piracetam did not provide additional benefits.
Article Abstract
Objectives: To investigate the efficiency of piracetam and acyclovir in treating sudden hearing loss.
Patients And Methods: Eightyone patients (44 males, 37 females; mean age 40.4 year; range 18 to 72 years) who had treatment between January 2002 and December 2006 with diagnosis of idiopathic sudden hearing loss were evaluated retrospectively. These patients were divided into four groups according to the treatment they received. The patients who had combined treatment constituted the first group; those who had combined treatment and piracetam the second; those who had combined treatment and acyclovir the third; those who had combined treatment, acyclovir, and piracetam the fourth group.
Results: For the four treatment groups, in the pre-and post-treatment (10th day) evaluation of the treatment efficiency made by calculation of the hearing thresholds in 250-8000 Hz frequencies, no significant difference between the groups was determined (p>0.05).
Conclusion: No additional benefit was obtained with acyclovir and piracetam in treatment.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!